Venture Certified
| 기술평가보증기업(기금) | 2017-06-13 ~ 2019-06-12 | 20170106539 | 2017-06-13 |
| 기술평가보증기업(기금) | 2019-06-13 ~ 2021-06-12 | 20190107911 | 2017-06-13 |
| 혁신성장유형 | 2021-06-13 ~ 2024-06-12 | 20210707030056 | 2017-06-13 |
| 혁신성장유형 | 2024-06-13 ~ 2027-06-12 | 20240724030049 | 2017-06-13 |
Revenue CAGR +21.5%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 16.8B | 8.9B | 11.4B |
| Operating Profit | -0.8B | -17.3B | -0.1B |
| Net Profit | -2.1B | -21.1B | -1.2B |
| Total Assets | 68.3B | 64.5B | 69.9B |
| Total Liabilities | 68.2B | 62.3B | 56.5B |
| Total Equity | 0.2B | 2.2B | 13.3B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Debt Ratio 42677.8%: Exceeds 400%, financial soundness risk
Operating Loss: Op. profit -837810K
3 Consecutive Years of Net Loss
Debt Ratio Surge (+39880pp YoY)
▲ 65.1%
▲ 90.4%
▲ 94.8%
▲ 2548.8%
▼ 170.8%
| Name | Position | Role |
|---|---|---|
| 이창택 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기 광주시",
"ceo_name": "이창택",
"certificate": [
{
"cert_number": "20170106539",
"changes": "",
"disclosure_date": "2017-06-13",
"first_cert_date": "2017-06-13",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2017-06-13 ~ 2019-06-12"
},
{
"cert_number": "20190107911",
"changes": "",
"disclosure_date": "2019-07-09",
"first_cert_date": "2017-06-13",
"no": "2",
"type": "기술평가보증기업(기금)",
"valid_period": "2019-06-13 ~ 2021-06-12"
},
{
"cert_number": "20210707030056",
"changes": "",
"disclosure_date": "2021-07-07",
"first_cert_date": "2017-06-13",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2021-06-13 ~ 2024-06-12"
},
{
"cert_number": "20240724030049",
"changes": "",
"disclosure_date": "2024-07-24",
"first_cert_date": "2017-06-13",
"no": "4",
"type": "혁신성장유형",
"valid_period": "2024-06-13 ~ 2027-06-12"
}
],
"company_name": "주식회사 바이오덴",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 950000000,
"cost_of_sales": 676095000,
"current_assets": 3089185000,
"current_liabilities": 3743933000,
"gross_profit": 460515000,
"net_income": -116416000,
"net_income_bs": -117719000,
"non_current_assets": 3896556000,
"non_current_liabilities": 1910000000,
"non_operating_expenses": 113990000,
"non_operating_income": 9979000,
"operating_profit": -12405000,
"revenue": 1136610000,
"sga_expenses": 472920000,
"total_assets": 6985741000,
"total_equity": 1331808000,
"total_liabilities": 5653933000
},
"2023": {
"capital_stock": 1450000000,
"cost_of_sales": 1621373000,
"current_assets": 3382576000,
"current_liabilities": 4100534000,
"gross_profit": -726449000,
"net_income": -2109120000,
"net_income_bs": -2109120000,
"non_current_assets": 3070646000,
"non_current_liabilities": 2130000000,
"non_operating_expenses": 383468000,
"non_operating_income": 25000,
"operating_profit": -1725677000,
"revenue": 894924000,
"sga_expenses": 999228000,
"total_assets": 6453222000,
"total_equity": 222688000,
"total_liabilities": 6230534000
},
"2024": {
"capital_stock": 1450000000,
"cost_of_sales": 1221744000,
"current_assets": 3807205000,
"current_liabilities": 4287219000,
"gross_profit": 455619000,
"net_income": -206715000,
"net_income_bs": -206715000,
"non_current_assets": 3025687000,
"non_current_liabilities": 2529700000,
"non_operating_expenses": 175531000,
"non_operating_income": 52593000,
"operating_profit": -83777000,
"revenue": 1677363000,
"sga_expenses": 539396000,
"total_assets": 6832892000,
"total_equity": 15973000,
"total_liabilities": 6816919000
}
},
"industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
"investment": [],
"main_products": "치과재료(지르코니아 블록, 컴포짓레진, 지그겔 등)",
"phone": "031-765-****",
"years": [
2024,
2023,
2022
]
}